Search Results - "Halassy, Beata"
-
1
Multi-Detection Size Exclusion Chromatography as an Advanced Tool for Monitoring Enzyme-Antibody Conjugation Reaction and Quality Control of a Final Product
Published in Molecules (Basel, Switzerland) (05-06-2023)“…The multi-detection size exclusion chromatography (SEC) has been recognized as an advanced analytical technique for the characterization of macromolecules and…”
Get full text
Journal Article -
2
Development of Improved High-Performance Liquid Chromatography Method for the Determination of Residual Caprylic Acid in Formulations of Human Immunoglobulins
Published in Molecules (Basel, Switzerland) (03-03-2022)“…Quality control of human immunoglobulin formulations produced by caprylic acid precipitation necessitates a simple, rapid, and accurate method for…”
Get full text
Journal Article -
3
Recovery of infective virus particles in ion-exchange and hydrophobic interaction monolith chromatography is influenced by particle charge and total-to-infective particle ratio
Published in Journal of chromatography. B, Analytical technologies in the biomedical and life sciences (01-06-2017)“…•Purification recovery of MeV and MuV by IEX is below 20%.•Recovery of MuV and MeV by HIC is around 60%.•MuV and MeV chromatography requires large channel…”
Get full text
Journal Article -
4
Snake Antivenoms-Toward Better Understanding of the Administration Route
Published in Toxins (01-06-2023)“…Envenomations induced by animal bites and stings constitute a significant public health burden. Even though a standardized protocol does not exist,…”
Get full text
Journal Article -
5
Roughness of Production Conditions: Does It Really Affect Stability of IgG-Based Antivenoms?
Published in Toxins (13-07-2022)“…Antivenoms contain either pure animal IgGs or their fragments as an active substance, and are the only specific therapeutics against envenomation arising from…”
Get full text
Journal Article -
6
Production- and Purification-Relevant Properties of Human and Murine Cytomegalovirus
Published in Viruses (10-12-2021)“…There is a large unmet need for a prophylactic vaccine against human cytomegalovirus (HCMV) to combat the ubiquitous infection that is ongoing with this…”
Get full text
Journal Article -
7
Refinement strategy for antivenom preparation of high yield and quality
Published in PLoS neglected tropical diseases (01-06-2019)“…Antivenoms from hyperimmune animal plasma are the only specific pharmaceuticals against snakebites. The improvement of downstream processing strategies is of…”
Get full text
Journal Article -
8
Comparison of Preclinical Properties of Several Available Antivenoms in the Search for Effective Treatment of Vipera ammodytes and Vipera berus Envenoming
Published in Toxins (13-03-2021)“…Snakebites are a relatively rare medical emergency in Europe. In more than half of the annual cases caused by , , and , immunotherapy with animal-derived…”
Get full text
Journal Article -
9
Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks
Published in Frontiers in immunology (17-05-2022)“…During the pre-vaccine era of the COVID-19 pandemic convalescent plasma has once again emerged as a major potential therapeutic form of passive immunization…”
Get full text
Journal Article -
10
Stability, biophysical properties and effect of ultracentrifugation and diafiltration on measles virus and mumps virus
Published in Archives of virology (01-06-2016)“…Measles virus and mumps virus (MeV and MuV) are enveloped RNA viruses used for production of live attenuated vaccines for prophylaxis of measles and mumps…”
Get full text
Journal Article -
11
What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?
Published in Human vaccines & immunotherapeutics (15-12-2023)“…During the SARS-CoV-2 pandemic, the lack of standardized measurements of the immune response after vaccination or recovery from COVID-19 resulted in…”
Get full text
Journal Article -
12
Biological Activities and Proteomic Profile of the Venom of Vipera ursinii ssp., a very Rare Karst Viper from Croatia
Published in Toxins (16-03-2020)“…The karst viper ( ssp.) favours high-mountain dry grasslands in southern and south-eastern Croatia. It is medically less important than other species, because…”
Get full text
Journal Article -
13
Intravenous Vipera berus Venom-Specific Fab Fragments and Intramuscular Vipera ammodytes Venom-Specific F(ab') 2 Fragments in Vipera ammodytes -Envenomed Patients
Published in Toxins (14-04-2021)“…( ) is the most venomous European viper. The aim of this study was to compare the clinical efficacy and pharmacokinetic values of intravenous venom-specific…”
Get full text
Journal Article -
14
Mass spectrometry-based investigation of measles and mumps virus proteome
Published in Virology journal (16-10-2018)“…Measles (MEV) and mumps virus (MUV) are enveloped, non-segmented, negative single stranded RNA viruses of the family Paramyxoviridae, and are the cause of…”
Get full text
Journal Article -
15
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
Published in Vaccines (Basel) (01-09-2024)“…Intratumoural oncolytic virotherapy may have promise as a means to debulk and downstage inoperable tumours in preparation for successful surgery. Here, we…”
Get full text
Journal Article -
16
Quality-Related Properties of Equine Immunoglobulins Purified by Different Approaches
Published in Toxins (14-12-2020)“…Whole IgG antivenoms are prepared from hyperimmune animal plasma by various refinement strategies. The ones most commonly used at industrial scale are…”
Get full text
Journal Article -
17
Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?
Published in Frontiers in immunology (22-02-2022)“…During the ongoing COVID-19 epidemic many efforts have gone into the investigation of the SARS-CoV-2-specific antibodies as possible therapeutics. Currently,…”
Get full text
Journal Article -
18
Streamlined downstream process for efficient and sustainable (Fab') 2 antivenom preparation
Published in The journal of venomous animals and toxins including tropical diseases (2020)“…Antivenoms are the only validated treatment against snakebite envenoming. Numerous drawbacks pertaining to their availability, safety and efficacy are becoming…”
Get full text
Journal Article -
19
A Single Dose of ViperfavTM May Be Inadequate for Vipera ammodytes Snake Bite: A Case Report and Pharmacokinetic Evaluation
Published in Toxins (19-08-2016)“…Viperfav TM is a commercial F(ab’) 2 antivenom prepared against European vipers venom. It is safe and effective for treating envenomation caused by Vipera…”
Get full text
Journal Article -
20
Adjuvant activity of peptidoglycan monomer and its metabolic products
Published in Vaccine (14-02-2003)“…Peptidoglycan monomer (PGM) is a natural compound of bacterial origin. It is a non-toxic, non-pyrogenic, water-soluble immunostimulator potentiating humoral…”
Get full text
Journal Article Conference Proceeding